These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16622469)

  • 1. ATM haplotypes and breast cancer risk in Jewish high-risk women.
    Koren M; Kimmel G; Ben-Asher E; Gal I; Papa MZ; Beckmann JS; Lancet D; Shamir R; Friedman E
    Br J Cancer; 2006 May; 94(10):1537-43. PubMed ID: 16622469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case-control study.
    Tamimi RM; Hankinson SE; Spiegelman D; Kraft P; Colditz GA; Hunter DJ
    Breast Cancer Res; 2004; 6(4):R416-22. PubMed ID: 15217510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk.
    Lee KM; Choi JY; Park SK; Chung HW; Ahn B; Yoo KY; Han W; Noh DY; Ahn SH; Kim H; Wei Q; Kang D
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):821-5. PubMed ID: 15824150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study.
    Einarsdóttir K; Rosenberg LU; Humphreys K; Bonnard C; Palmgren J; Li Y; Li Y; Chia KS; Liu ET; Hall P; Liu J; Wedrén S
    Breast Cancer Res; 2006; 8(6):R67. PubMed ID: 17132159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATM haplotypes and associated mutations in Iranian patients with ataxia-telangiectasia: recurring homozygosity without a founder haplotype.
    Babaei M; Mitui M; Olson ER; Gatti RA
    Hum Genet; 2005 Jul; 117(2-3):101-6. PubMed ID: 15843990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haplotypes at ATM identify coding-sequence variation and indicate a region of extensive linkage disequilibrium.
    Bonnen PE; Story MD; Ashorn CL; Buchholz TA; Weil MM; Nelson DL
    Am J Hum Genet; 2000 Dec; 67(6):1437-51. PubMed ID: 11078475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.
    Renwick A; Thompson D; Seal S; Kelly P; Chagtai T; Ahmed M; North B; Jayatilake H; Barfoot R; Spanova K; McGuffog L; Evans DG; Eccles D; ; Easton DF; Stratton MR; Rahman N
    Nat Genet; 2006 Aug; 38(8):873-5. PubMed ID: 16832357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five haplotypes account for fifty-five percent of ATM mutations in Brazilian patients with ataxia telangiectasia: seven new mutations.
    Coutinho G; Mitui M; Campbell C; Costa Carvalho BT; Nahas S; Sun X; Huo Y; Lai CH; Thorstenson Y; Tanouye R; Raskin S; Kim CA; Llerena J; Gatti RA
    Am J Med Genet A; 2004 Apr; 126A(1):33-40. PubMed ID: 15039971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The founder mutations in the BRCA1, BRCA2, and ATM genes in Moroccan Jewish women with breast cancer.
    Kreiss Y; Barak F; Baruch RG; Levy-Lahad E; Pras E; Friedman E
    Genet Test; 2000; 4(4):403-7. PubMed ID: 11216667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk.
    Baynes C; Healey CS; Pooley KA; Scollen S; Luben RN; Thompson DJ; Pharoah PD; Easton DF; Ponder BA; Dunning AM;
    Breast Cancer Res; 2007; 9(2):R27. PubMed ID: 17428325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-stage case-control study of common ATM gene variants in relation to breast cancer risk.
    Ye C; Dai Q; Lu W; Cai Q; Zheng Y; Shu XO; Gu K; Gao YT; Zheng W
    Breast Cancer Res Treat; 2007 Nov; 106(1):121-6. PubMed ID: 17431766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma.
    Malmer BS; Feychting M; Lönn S; Lindström S; Grönberg H; Ahlbom A; Schwartzbaum J; Auvinen A; Collatz-Christensen H; Johansen C; Kiuru A; Mudie N; Salminen T; Schoemaker MJ; Swerdlow AJ; Henriksson R
    J Neurooncol; 2007 May; 82(3):229-37. PubMed ID: 17151932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGFR2 is a breast cancer susceptibility gene in Jewish and Arab Israeli populations.
    Raskin L; Pinchev M; Arad C; Lejbkowicz F; Tamir A; Rennert HS; Rennert G; Gruber SB
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1060-5. PubMed ID: 18483326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for ATM sequence alterations in African-American women diagnosed with breast cancer.
    Hirsch AE; Atencio DP; Rosenstein BS
    Breast Cancer Res Treat; 2008 Jan; 107(1):139-44. PubMed ID: 17333338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the linkage disequilibrium structure and identification of tagging-SNPs in five DNA repair genes.
    Allen-Brady K; Camp NJ
    BMC Cancer; 2005 Aug; 5():99. PubMed ID: 16091150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants.
    Hall J
    Cancer Lett; 2005 Sep; 227(2):105-14. PubMed ID: 16112413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATM mutations, haplotype analysis, and immunological status of Russian patients with ataxia telangiectasia.
    Birrell GW; Kneebone K; Nefedov M; Nefedova E; Jartsev MN; Mitsui M; Gatti RA; Lavin MF
    Hum Mutat; 2005 Jun; 25(6):593. PubMed ID: 15880721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer.
    Schrauder M; Frank S; Strissel PL; Lux MP; Bani MR; Rauh C; Sieber CC; Heusinger K; Hartmann A; Schulz-Wendtland R; Strick R; Beckmann MW; Fasching PA
    J Cancer Res Clin Oncol; 2008 Aug; 134(8):873-82. PubMed ID: 18264724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the proposed association of the ATM variants 5557G>A and IVS38-8T>C and bilateral breast cancer.
    Langholz B; Bernstein JL; Bernstein L; Olsen JH; Børresen-Dale AL; Rosenstein BS; Gatti RA; ; Concannon P
    Int J Cancer; 2006 Aug; 119(3):724-5. PubMed ID: 16496408
    [No Abstract]   [Full Text] [Related]  

  • 20. A specific RAD51 haplotype increases breast cancer risk in Jewish non-Ashkenazi high-risk women.
    Gal I; Kimmel G; Gershoni-Baruch R; Papa MZ; Dagan E; Shamir R; Friedman E
    Eur J Cancer; 2006 May; 42(8):1129-34. PubMed ID: 16624550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.